mYXpression is a French start-up in the field of AI-based predictive diagnostics for auto immune diseases. Our proprietary technology exploits multi-omics data to predict patient's response to biologics. Our unique offering enables patient triage (predictive enrichment) during phases 2 and 3, thus reducing costs, delays and risks of failure.